Literature DB >> 16209917

Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol-starch components.

W Weyenberg1, S Bozdag, P Foreman, J P Remon, A Ludwig.   

Abstract

The purpose of this study was to evaluate different bioadhesive ocular formulations based on drum dried waxy maize starch (DDWM), Amioca starch and Carbopol 974P. The concentrations of Carbopol 974P in the mixtures varied between 5 and 25% (w/w). The rheological properties of the non-sterilized and gamma-irradiated physical blends of Carbopol 974P with either DDWM or Amioca were compared to those of the corresponding co-spray dried Amioca starch/Carbopol powders. Higher viscosity or consistency values were measured for sterilized co-spray dried powder mixtures containing an amount of Carbopol 974P equal or above 15% (w/w) compared to the physical blends. Sustained release minitablets (2 mm, 6 mg), consisting of sodium fluorescein as model drug and the bioadhesive powders, were manufactured at a compression force of 1.25 kN. Afterwards, the tablets were sterilized with gamma-irradiation. The amount of Carbopol in the co-spray dried powder mixtures on the one hand and gamma-irradiation on the other hand had no significant influence on the crushing strength and friability of the minitablets evaluated. However, these two factors affected the in vitro release properties of the minitablets. The slowest release was obtained with tablets containing 25% Carbopol 974P, which unfortunately possess mucosal irritating properties. By using co-spray dried Amioca with 15% (w/w) Carbopol 974P, a slower release can be achieved compared to the physical mixtures of DDWM or Amioca starch with Carbopol 974P. Moreover, this ocular formulation is very promising and is preferred, as it did not cause any mucosal irritation and released the model drug for at least 12 h, after application in the fornix.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209917     DOI: 10.1016/j.ejpb.2005.08.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  4 in total

1.  Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma.

Authors:  Prakash Bhagav; Vaibhav Trivedi; Darshan Shah; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

2.  Anhydride prodrug of ibuprofen and acrylic polymers.

Authors:  Boaz Mizrahi; Abraham J Domb
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

3.  Tissue Adhesives: From Research to Clinical Translation.

Authors:  Ayça Bal-Ozturk; Berivan Cecen; Meltem Avci-Adali; Seda Nur Topkaya; Emine Alarcin; Gokcen Yasayan; Yi-Chen Ethan; Bunyamin Bulkurcuoglu; Ali Akpek; Huseyin Avci; Kun Shi; Su Ryon Shin; Shabir Hassan
Journal:  Nano Today       Date:  2020-12-20       Impact factor: 20.722

4.  Formulation and In-Vitro Evaluation of Ocular Ciprofloxacin-Containing Minitablets Prepared with Different Combinations of Carbopol 974P and Various Cellulose Derivatives.

Authors:  Seyed Alireza Mortazavi; Zahra Jaffariazar; Elnaz Damercheli
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.